Targeting MYC and NOTCH2 also decreased the capacity for self-renewal and tumor formation corroborating the importance of the MUC1-C→MYC→NOTCH2 pathway in driving the SCLC CSC state. Here, NOTCH2 is linked to small cell lung carcinoma.